Skip to content

The effect of exosomes on dry eye

Examining the health and effectiveness of using exosomes derived from limbal mesenchymal stem cells in dry eye patients

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20231022059814N1
Enrollment
30
Registered
2023-11-11
Start date
2023-12-06
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry eye. Dry eye syndrome

Interventions

Intervention 1: Intervention group: Patients with dry eyes, will receive in the right eye, one drop (0.05 cc) of exosome derived from limbal mesenchymal stem cells with a concentration of 0.01 micro l

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients with complaints of burning or itching or feeling of a foreign body in the eye Moderate and severe dry eye severity Age between 18-70 years

Exclusion criteria

Exclusion criteria: Previous history of eye surgery Any disease that suppresses the immune system Pregnancy and breastfeeding Eyelid abnormalities Use of eye drops in the past year except artificial tears and lubricating ointments Use of systemic drugs that affect the tear film in last three months Use of systemic steroid in the last three months Use of contact lenses in the last three months

Design outcomes

Primary

MeasureTime frame
Dry eye. Timepoint: Before the intervention, 4 and 12 weeks after the intervention. Method of measurement: Based on the ocular surface disease index questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHossein Aghaei

Iran University of Medical Sciences

draghaei.h@gmail.com+98 21 6655 8811

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026